fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases — Stella

Home/Invasive Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Invasive Breast Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

European Institute of Oncology, Milan

Key details

Sponsor

European Institute of Oncology

Enrollment target

~145 participants

Started

November 2019

Primary completion

December 2028

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.